908 Devices (MASS) Scheduled to Post Earnings on Tuesday

908 Devices (NASDAQ:MASS - Get Free Report) is scheduled to be announcing its earnings results before the market opens on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Investors that wish to register for the company's conference call can do so using this link.

908 Devices (NASDAQ:MASS - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($0.32) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.34) by $0.02. The firm had revenue of $14.05 million for the quarter, compared to analyst estimates of $13.69 million. 908 Devices had a negative return on equity of 22.47% and a negative net margin of 72.10%. On average, analysts expect 908 Devices to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

908 Devices Trading Up 9.6 %

NASDAQ MASS traded up $0.32 on Tuesday, reaching $3.66. 195,932 shares of the company were exchanged, compared to its average volume of 192,479. The business's fifty day moving average price is $3.54 and its 200 day moving average price is $4.80. The stock has a market capitalization of $126.86 million, a P/E ratio of -3.18 and a beta of 0.98. 908 Devices has a fifty-two week low of $3.13 and a fifty-two week high of $12.51.

Wall Street Analyst Weigh In

Separately, Leerink Partners lowered their price objective on 908 Devices from $15.00 to $12.00 and set an "outperform" rating on the stock in a research note on Thursday, October 17th.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.